MedPath
FDA Approval

NOREPINEPHRINE BITARTRATE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
NorthStar Rx LLC
DUNS: 830546433
Effective Date
December 1, 2023
Labeling Type
Human Prescription Drug Label
Norepinephrine(1 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Caplin Steriles Limited

650744670

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Caplin Steriles Limited

NorthStar Rx LLC

Caplin Steriles Limited

650744670

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NOREPINEPHRINE BITARTRATE

Product Details

NDC Product Code
72603-180
Application Number
ANDA217575
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
December 1, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
Code: IFY5PE3ZRWClass: ACTIMQuantity: 1 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
NOREPINEPHRINE BITARTRATE - FDA Approval | MedPath